Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
25mg
|
|||
Strength
100mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Lorbrena is an oral tyrosine kinase inhibitor specifically prescribed for the treatment of certain forms of advanced non-small cell lung cancer (NSCLC). It is typically only prescribed by oncologists for the treatment of cancer.
It is a targeted therapy effective against tumors with specific genetic mutations like ALK (anaplastic lymphoma kinase) rearrangements.
Fact Table | |
---|---|
Formula | C21H19FN6O2 |
License | FDA approved |
Bioavailability | Approximately 81% |
Legal status | Prescription only |
Chemical Name | 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-5-(1-(2-(dimethylamino)ethyl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-1,4(2H,3H)-dione |
Elimination half-life | Approximately 24 hours |
Dosage (Strength) | 25 mg, 100 mg tablets |
Pregnancy | Not recommended; consult a healthcare provider |
Brands | Lorbrena |
Protein binding | Approximately 66% |
PubChem CID | 71719489 |
MedlinePlus | a618054 |
ChEBI | 134698 |
ATC code | L01XE56 |
DrugBank | DB11749 |
KEGG | D10957 |
Routes of administration | Oral |
The recommended dosage is 100 mg once daily. Do not change or adjust your dosage without speaking with your doctor.
The active ingredient in Lorbrena is loralatinib.
Common drug-drug interactions may include:
Ask your doctor or pharmacist for a full list of precautions that apply to you.
Common adverse reactions may include:
Lorbrena [package insert]. New York, NY: Pfizer; November 2018.